🇺🇸 FDA
Company

Maze

Maze Therapeutics

MAZE biotech USA

Quick answer

Maze is a biotech company (MAZE) headquartered in SOUTH SAN FRANCISCO, CA, USA with 2 tracked pipeline programs.

Pipeline (2)

project

MZE829

Proteinuric Kidney Disease

Phase 2 · small_molecule · active

1 trials project

MZE001

Healthy

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12310943

Compositions and methods for improving mitochondrial function and treating neuro

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12297182

Compositions comprising an urolithin compound

Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12226455

Medical composition for treating cardiac wasting and cachexia

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12220424

Compositions comprising nicotinamide riboside and a urolithin

Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12109190

Urolithins as immune response enhancers

Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12036205

Compositions and methods for improving mitochondrial function and treating neuro

Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12030863

Prodrugs of urolithins and uses thereof

Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11969408

Method for improving mitophagy in subjects

Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)